Calyxt Investor Presentation from 2022 LD Micro Invitational

Roseville, MN – Friday, June 17, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, participated recently at the annual investor conference, “LD Micro Invitational.” Speaking on behalf of Calyxt was President and CEO Michael A. Carr.

Calyxt, Inc @ the LD Micro Invitational
Date: Wednesday, June 8, 2022
Time: 10:30 a.m. ET (7:30 a.m. PT)
Webcast:Link to view event

The presentation is available for viewing and replay on the link above.

To schedule or learn about additional investor conversations with Calyxt, please reach out to

About Calyxt

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers’ materials and products. As plant-based solutions, the Company’s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit

PlantSpring, BioFactory, and the Calyxt logo are trademarks of Calyxt, Inc.


Calyxt Media Contact: Calyxt Investor Relations Contact:
Brennan Burks/ David Rosen/ John Garabo/ Michael Barron
Calyxt Communications/Argot Partners
(212) 600-1902  
Kimberly Minarovich/ Cameron Willis 
Argot Partners
(212) 600-1902  
Calyxt Business Development Contact:
Gerry Nuovo
Senior Vice President of Business Development
(612) 427-7881